FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-140566.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-140566v1
fj.09-140566v2
24/2/415    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Herron, T. J.
Right arrow Articles by Metzger, J. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herron, T. J.
Right arrow Articles by Metzger, J. M.
(The FASEB Journal. 2010;24:415-424.)
© 2010 FASEB

Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by {alpha}-myosin motor gene transfer

Todd J. Herron*,{dagger},1, Eric Devaney{ddagger},1, Lakshmi Mundada{ddagger}, Erik Arden||, Sharlene Day§, Guadalupe Guerrero-Serna{dagger}, Immanuel Turner*, Margaret Westfall*,{ddagger} and Joseph M. Metzger||,2

* Department of Molecular and Integrative Physiology,

{dagger} Center for Arrhythmia Research,

{ddagger} Department of Cardiac Surgery, and

§ Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA; and

|| Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, Minnesota, USA

2 Correspondence: Department of Integrative Biology and Physiology, University of Minnesota, Medical School, 6-125 Jackson Hall, 321 Church St. SE, Minneapolis, MN 55455, USA. E-mail: metzgerj{at}umn.edu

Current inotropic therapies used to increase cardiac contractility of the failing heart center on increasing the amount of calcium available for contraction, but their long-term use is associated with increased mortality due to fatal arrhythmias. Thus, there is a need to develop and explore novel inotropic therapies that can act via calcium-independent mechanisms. The purpose of this study was to determine whether fast {alpha}-myosin molecular motor gene transfer can confer calcium-independent positive inotropy in slow β-myosin-dominant rabbit and human failing ventricular myocytes. To this end, we generated a recombinant adenovirus (AdMYH6) to deliver the full-length human {alpha}-myosin gene to adult rabbit and human cardiac myocytes in vitro. Fast {alpha}-myosin motor expression was determined by Western blotting and immunocytochemical analysis and confocal imaging. In experiments using electrically stimulated myocytes from ischemic failing hearts, AdMYH6 increased the contractile amplitude of failing human [23.9±7.8 nm (n=10) vs. AdMYH6 amplitude 78.4±16.5 nm (n=6)] and rabbit myocytes. The intracellular calcium transient amplitude was not altered. Control experiments included the use of a green fluorescent protein or a β-myosin heavy chain adenovirus. Our data provide evidence for a novel form of calcium-independent positive inotropy in failing cardiac myocytes by fast {alpha}-myosin motor protein gene transfer.—Herron, T. J., Devaney, E., Mundada, L., Arden, E., Day, S., Guerrero-Serna, G., Turner, I., Westfall, M., Metzger, J. M. Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by {alpha}-myosin motor gene transfer.


Key Words: cardiac gene transfer • ischemic heart failure • adenoviral gene transfer







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2010 by The Federation of American Societies for Experimental Biology.